|
|
|
Primate Animal
Model Services
pPrimate
animal characteristics are close to human
characteristics. This is especially true in
terms of similarities in tissue structure, the
immune system, physiology, and metabolism.
Nonhuman primate animal models have become not
only a bridge to connect basic research and
clinical application, but also an ideal model
for human health and disease research.
w
wAccording
to FDA regulations, all drug candidates
for Neurological diseases, such as
Alzheimer's disease and Parkinson's
disease, must pass nonhuman primate
animal tests before processing into
clinical trials. In addition, all
cell-based therapies and gene-therapies
are also required to go through nonhuman
primate animal tests before advancing to
a phase I clinical trial. Nonhuman
primate animal models need to be
established for the research of the
following important human diseases, such
as AIDS, SARS, autoimmune
system
diseases, old age diseases, and other
gene defective diseases.
Biochain has teamed up with
contract research organizations
(CROs), which are fully
accredited by AAALAC
international, and exclusively
focus on primate resources. We
have a very strong team
of scientists, researchers,
veterinarians, and technicians,
who are actively engaged in
developing nonhuman primate
models for studies of drug
safety, drug pharmacokinetics,
drug efficacy, and cell and gene
therapies, particularly for
neurological disorders and
aging-related diseases.
Currently we have nonhuman
primate models of Parkinson's
disease and Diabetic disease.
We are able to provide the
following services
w
w
-
Disease Models: Parkinson's
disease and Diabetes
-
Drug efficacy test
-
Long-term toxicity including fetal
toxicity testing
-
PK and PD studies in primates
-
Cell therapy and gene therapy tests
Advantages
-
Guaranteed high quality service in facilities
accredited by AAALAC
-
Unique expertise and clinical
resources on disease modeling, including Parkinson's
disease, diabetes (chemical induced and nature
model) and others
-
Strong research and project
management team
including
many well experienced scientists with Ph.D.'s and M.D.'s
degrees.
-
Strong support from central and local
government and academic institutions
-
Well established
reputation including successful collaboration with U.S.
research institutions and
pharmaceutical
companies.
-
Access to rich primate resources
(more than 30,000
cynomolgus
monkeys)
-
Lower prices than most of
our competitors
Age associated decrease
in Striatal 99mTc-TRODAT-1 uptake ratio from a monkey of
4 years old (A), 10 years old (B) and 15 years old(C)
were measured by SPECT in our facility
|
| Detail
Pricing |
|
Please
download the
questionnaire, fill it and either email to us at
info@biochain.com
or fax to us at 510-783-5386. An official
quotation of each service will be offered after detailed
communications. |
|
|
|
|
